Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi Jun 23, 2026 02:09PM
Coherus BioSciences (CHRS) Reports In-Line Q1 EPS May 11, 2026 04:05PM
Oppenheimer Reiterates Outperform Rating on Coherus Biosciences (CHRS): "buying opportunity ahead of key catalysts" Mar 10, 2026 08:15AM
Coherus BioSciences (CHRS) Reports In-Line Q4 EPS Mar 9, 2026 04:24PM
H.C. Wainwright Reiterates Buy Rating on Coherus Biosciences (CHRS) Feb 5, 2026 06:52AM


Feb 4, 2026 01:28PM Oppenheimer on Coherus Biosciences (CHRS): 'We see potential for CHRS shares to build on recent gains'
Jan 22, 2026 04:09PM Oppenheimer Starts Coherus Biosciences (CHRS) at Outperform
Jan 5, 2026 09:30AM Coherus announces publication of CCR8 antibody tagmokitug research data
Dec 8, 2025 08:32AM Coherus reports extended survival data for LOQTORZI cancer treatment
Nov 7, 2025 09:00AM Coherus presents data on CHS-114 cancer drug at SITC conference
Nov 6, 2025 04:27PM Coherus BioSciences (CHRS) Misses Q3 EPS by 1c, Misses on Revenue
Nov 6, 2025 01:55PM Coherus Oncology names Arvind Sood as chief strategy officer
Sep 4, 2025 07:57AM Maxim Group Upgrades Coherus Biosciences (CHRS) to Buy, PT $4
Aug 7, 2025 04:43PM Coherus BioSciences (CHRS) Misses Q2 EPS by 8c
May 13, 2025 07:28AM Coherus BioSciences (CHRS) Misses Q1 EPS by 205c
Apr 29, 2025 07:29AM H.C. Wainwright Reiterates Buy Rating on Coherus Biosciences (CHRS)
Apr 28, 2025 10:14AM Coherus BioSciences (CHRS) announces promising data from CHS-114 trial
Apr 1, 2025 08:02AM Coherus BioSciences (CHRS) Announces Repurchase of Approximately $170M of Convertible Notes
Mar 11, 2025 06:52AM H.C. Wainwright Upgrades Coherus Biosciences (CHRS) to Buy
Mar 10, 2025 04:15PM Coherus BioSciences (CHRS) Tops Q4 EPS by 2c
Dec 5, 2024 06:54AM Coherus Biosciences (CHRS) PT Raised to $6 at Baird
Dec 4, 2024 06:47AM Coherus Biosciences (CHRS) PT Lowered to $7 at H.C. Wainwright
Dec 3, 2024 10:14AM Coherus BioSciences (CHRS) Announces Agreement to Divest UDENYCA Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
Dec 3, 2024 08:14AM Citi Out Positive on Coherus Biosciences (CHRS): 'Erasing the $230M convert debt due in 2026 extinguishes a much-debated overhang'
Nov 6, 2024 05:23PM Coherus BioSciences (CHRS) Tops Q3 EPS by 15c
Oct 7, 2024 09:22AM TD Cowen Reiterates Buy Rating on Coherus Biosciences (CHRS)
Sep 16, 2024 09:48AM Baird Reiterates Outperform Rating on Coherus Biosciences (CHRS)
Aug 16, 2024 02:15AM UBS Downgrades Coherus Biosciences (CHRS) to Neutral
Aug 8, 2024 04:52PM Coherus BioSciences (CHRS) Tops Q2 EPS by 11c ; Offers Guidance
Jul 1, 2024 07:00AM Coherus Biosciences (CHRS) PT Lowered to $8 at Baird
Jun 27, 2024 08:27AM Coherus BioSciences (CHRS) to Sell YUSIMRY for $40M Cash